Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression
October 28, 2010•14 min
Host: Mary Leuchars, MD
Guest: Christopher Slatore, MD
Systemic corticosteroids increase the risk of diabetes, but what about in patients who take high-dose inhaled corticosteroids? How do we best manage the risk-benefit equation in patients with chronic obstructive pulmonary disease (or COPD)? Dr. Christopher Slatore, assistant professor in the division of pulmonary and critical care medicine,&nbsp;Portland VA Medical Center /&nbsp;Oregon Health and Sciences University, in&nbsp;Portland, Oregon, discusses the association between inhaled corticosteroid use and serum glucose concentration. Dr. Mary Leuchars hosts.